MedCity News

Health Tech

Zus Health Raises $33M to Make Healthcare More Connected

By Marissa Plescia

BioPharma

Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs

Windward Bio’s next-generation antibody drugs for immunology caught the interest of Sanofi, which bought shares in a private placement alongside the biotech’s IPO. Windward’s lead drug candidate addresses the same target as a blockbuster asthma drug from partners Amgen and AstraZeneca.

By Frank Vinluan

Sponsored Post

Biosensors and Wearables Among MedTech Showcased at INVEST Digital Health

ARPA-H portfolio companies in the Innovation Showcase included biosensor and wearable startups to monitor vital signs and to obtain patient data previously only available through blood tests.

By Stephanie Baum

MedCity Influencers

Pay Transparency in Life Sciences: Staying Ahead of Emerging Regulatory Complexity

In an industry characterized by intense competition for specialized and high-level talent and complex compensation structures, leaders must treat pay transparency not merely as a compliance requirement, but as a strategic priority requiring strong internal alignment across an evolving global landscape.

By Brett Anders, Matthew Epstein and Margaret Strange

Latest Video

Latest News

presented by

Sponsored Post, Events

What’s Missing from Healthcare Quality Conversations?

Jason Tibbels, MD, Lantern Chief Medical Officer, described the company’s approach to making care more affordable without undermining quality or health outcomes in an interview with MedCity News Editor-in-Chief Arundhati Parmar at INVEST Digital Health.

By Stephanie Baum

MedCity Influencers

How Politics Became Every Hospital’s Brand Risk

When governments fall short on public health, hospitals inherit the fallout. Those with the strongest brands are best positioned to withstand it.

By David Haigh

presented by

Sponsored Post, Artificial Intelligence

Automation Didn’t Dehumanize Care. Bad Systems Did.

We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

Policy

62 Organizations Call on Congress to Advance 4 Medicare Reforms

The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care.

By Marissa Plescia

BioPharma, Pharma

Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials

Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal.

By Frank Vinluan

Artificial Intelligence, Hospitals

Is AI Really Saving Hospitals Money? A New Study Raises Questions About the Cost of AI-Driven Care

Healthcare systems are investing in AI to streamline workflows and save money, but a new study in the New England Journal of Medicine shows that AI-generated care plans might actually cost far more than those ordered by physicians. .

By Jenna Congdon

presented by

Sponsored Post

From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS

What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.

By Anna Keith, Vice President of LTSS Product & Strategy at Centene Corporation, and Phyllis Wojtusik, RN, Executive Vice President of Value-Based Care at Real Time Medical Systems

presented by

Sponsored Post, Hospitals

Sustaining Effective Care Teams During Staff Shortages 

Join us on December 9 at 1 p.m. ET for an Inovalon-sponsored webinar, where panelists will discuss why hospitals and post-acute care facilities continue to struggle with staffing shortages and turnover. They will also share practical ways to keep employees engaged, reduce burnout, and build more stable care teams.

By Stephanie Baum

Opinion

When the Enrollment Freeze Ends, Claim Review Takes Over — Small Providers Need Clear Rules

A large health system absorbs an appeal as routine. For a small agency with a few office staff, every hour chasing a physician signature or a face-to-face note is an hour not spent on patients.

By Jamie Davis

presented by

Sponsored Post

The Healthcare Payments Industry Faces a Perception Challenge

Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.

By Lisa Brooks, Vice President, Healthcare Partnerships

MedCity Influencers

Beyond Metrics: How to Repair Our Relationship With Wearables

Users are, rightfully, upset that the devices they bought are not delivering the results they were promised. But is that indignation pointed at the right flaw?

By Emma Biggs

BioPharma, Pharma

Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy

Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals.

By Frank Vinluan

Health Tech

Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans

Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide.

By Marissa Plescia

Payers

Democrats’ Midterm Wins Could Reshape Healthcare Access for Underserved Americans

Democrats' huge wins last week might mean big changes coming to healthcare across the country, especially in states which flipped blue. How might the shift in power affect affordability, access, and coverage?

By Jenna Congdon

presented by

Sponsored Post, Devices & Diagnostics

Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality?

In an interview, Wayne Luan, senior director, life sciences and provider solutions with Turquoise Health, told MedCity News Editor-in-Chief Arundhati Parmar that the company's platform provides pricing data for medical services, medical devices, and pharmaceutical drugs.

By Stephanie Baum

MedCity Influencers

Follow the Leader: How to Build and Retain Great Clinical Teams

We spend more than a decade training physicians and teach them almost nothing about leading people. So, what do we do? We take the best clinician in the group, hand them the title, and assume that leadership comes with it.

By Sergio Zanotti

Artificial Intelligence, Consumer / Employer

Oura Buys Counsel for $625M, But Will Payers and Consumers Get on Board?

Oura will be integrating Counsel Health's clinical AI and virtual care into its app, but will payers and employers cover the Oura ring as a benefit? And will consumers sign on to pay a much more expensive monthly subscription for AI-enabled medical insights and access to licensed physicians?

By Arundhati Parmar

BioPharma, Pharma

FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke

Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class of cardiovascular medicines. Approval of the once-daily pill covers secondary stroke prevention in adults.

By Frank Vinluan